Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012
CME ACTIVITY - Research

Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010

Michael G. BakerComments to Author , Amanda Kvalsvig, Jane Zhang, Rob Lake, Ann Sears, and Nick Wilson
Author affiliations: University of Otago, Wellington, New Zealand (M.G. Baker, A. Kvalsvig, J. Zhang, A. Sears, N. Wilson); Institute of Environmental Science and Research, Christchurch, New Zealand (R. Lake)

Main Article

Table 4

Distribution of campylobacteriosis and GBS cases, by age, New Zealand, July 1995–December 2008*

Age group, y Campylobacteriosis notifications

Camplyobacteriosis hospitalizations
GBS hospitalizations
GBS hospitalizations associated with camplylobacteriosis
No. (%) Rate‡ No. (%) Rate‡ No. (%) Rate‡ No. (%) Rate‡
<5 15,232 (11.7) 442.5 538 (6.4) 13.9 45 (3.4) 1.2 0 0
5–9 6,295 (4.9) 176.9 200 (2.4) 5.0 33 (2.5) 0.8 2 (5.9) 0.1
10–19 14,481 (11.2) 203.7 965 (11.4) 12.2 113 (8.6) 1.4 3 (8.8) 0
20–29 25,063 (19.3) 385.9 1,509 (17.9) 20.6 115 (8.7) 1.6 1 (2.9) 0
30–39 19,511 (15.0) 270.7 935 (11.1) 11.5 146 (11.1) 1.8 3 (8.8) 0
40–49 16,572 (12.8) 237.0 747 (8.8) 9.6 149 (11.3) 1.9 5 (14.7) 0.1
50–59 14,311 (11.0) 261.9 778 (9.2) 13.0 226 (17.1) 3.8 6 (17.7) 0.1
60–69 9,559 (7.4) 255.7 824 (9.8) 19.9 209 (15.8) 5.0 7 (20.6) 0.2
70–79 6,174 (4.8) 235.9 1,046 (12.4) 35.9 200 (15.2) 6.9 5 (14.7) 0.2
>80 2,712 (2.1) 190.8 906 (10.7) 57.9 84 (6.4) 5.4 2 (5.9) 0.1
Total 129,910 (100.0) 270.4 8,448 (100.0) 15.8 1,320 (100.0) 2.5 34 (100.0) 0.1

*GBS, Guillain-Barré syndrome.
†Association with hospitalization for camplylobacteriosis. Includes subsequent and concurrent hospitalizations (campylobacteriosis and GBS diagnoses at time of hospital discharge).
‡Average annual no./100,000 population.

Main Article

Page created: January 26, 2012
Page updated: January 26, 2012
Page reviewed: January 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external